Trifecta Capital Advisors’s Armata Pharmaceuticals ARMP Stock Holding History

Trifecta Capital Advisors’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.63K	Hold	714	–	–	﹤0.01%	270
2026 Q1	$7.31K	Hold	714	–	–	﹤0.01%	239
2025 Q4	$4.48K	Hold	714	–	–	﹤0.01%	244
2025 Q3	$2.13K	Hold	714	–	–	﹤0.01%	329
2025 Q2	$1.36K	Hold	714	–	–	﹤0.01%	394
2025 Q1	$1.04K	Hold	714	–	–	﹤0.01%	370
2024 Q4	$1.32K	Hold	714	–	–	﹤0.01%	348
2024 Q3	$1.69K	Hold	714	–	–	﹤0.01%	332
2024 Q2	$1.96K	Hold	714	–	–	﹤0.01%	316
2024 Q1	$2.98K	Hold	714	–	–	﹤0.01%	264
2023 Q4	$2.31K	Hold	714	–	–	﹤0.01%	311
2023 Q3	$2.14K	Hold	714	–	–	﹤0.01%	301
2023 Q2	$814	Hold	714	–	–	﹤0.01%	386
2023 Q1	$1.19K	Hold	714	–	–	﹤0.01%	355
2022 Q4	$885	Buy	+714	New	+$1.86K	﹤0.01%	384

Other funds holding ARMP

MAM

Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Trifecta Capital Advisors's ARMP Position: Q2 2026 in Review

Trifecta Capital Advisors held its Armata Pharmaceuticals (ARMP) position steady in Q2 2026 at 714 shares worth $4.63K. The position accounts for ﹤0.01% of the portfolio, ranked #270.

Trifecta Capital Advisors first reported a position in ARMP in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.31K in Q1 2026. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

Trifecta Capital Advisors held 714 shares of Armata Pharmaceuticals worth $4.63K as of Q2 2026.
Trifecta Capital Advisors left its Armata Pharmaceuticals share count unchanged in Q2 2026.
Armata Pharmaceuticals made up ﹤0.01% of Trifecta Capital Advisors's portfolio in Q2 2026, its #270 holding.
Trifecta Capital Advisors first reported a position in Armata Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
Trifecta Capital Advisors's Armata Pharmaceuticals position peaked at $7.31K in Q1 2026.
53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Trifecta Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.